Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 05 Jun 2026 for DEXCOM INC, €309k. Read the official filing
Filing timeline
BuySaleJon Coleman
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jon Coleman: trading record in brief
This profile gathers the share dealings of Jon Coleman in Dexcom Inc. Between 22 May 2025 and 4 June 2026, the trades on record add up to 5 filings.
Sales make up the whole of the open-market record (2 sales, €622k). The rest of the record consists of 3 share grants. 2026 to date brings no purchases and 2 sales.
The newest entry dates from 5 June 2026: an open-market sale of €309k, in Dexcom Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jon Coleman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
4,912 shares@ US$73.000.0012% mcap28.6% of flowCommon StockSEC:0001093557-26-000127:0
4,911 shares@ US$74.130.0012% mcap29.1% of flowCommon StockSEC:0001093557-26-000127:1
7,362 shares@ US$71.900.0016% mcap100.0% of flowCommon StockSEC:0001093557-26-000095:0
43,897 shares0Common StockSEC:0001093557-26-000045:0
68,738 shares0Common StockSEC:0001093557-25-000195:0
5 of 5 declarations
